Eli Lilly Plans to Acquire Kelonia Therapeutics for Over $2 Billion to Expand Oncology Portfolio
The American pharmaceutical corporation Eli Lilly is in the final stages of negotiations to acquire the biotechnology company Kelonia Therapeutics.…
oncology